The pharmaceutical industry is no stranger to fierce competition and patent disputes. In recent years, one drug has taken the market by storm and achieved blockbuster status. Ozempic, a medication for the treatment of type 2 diabetes, has garnered significant attention and popularity. However, its manufacturer, Novo Nordisk, finds itself in a battle to protect… Continue reading The Maker of Ozempic Is Trying to Block Compounded Versions of Its Blockbuster Drug
Category: compounded
The Crackdown on Compounded GLP-1 Meds Has Begun
The Crackdown on Compounded GLP-1 Meds Has Begun In recent years, the medical community has witnessed a surge in the popularity of compounded medications. Compounded drugs are made by pharmacists who specialize in manipulating the ingredients of prescription drugs to meet specific needs of individual patients. While this practice has its merits, concerns have been… Continue reading The Crackdown on Compounded GLP-1 Meds Has Begun